Introduction
donor lymphocytes against the erythrocytes of the recipient. After the initial drop the haemoglobin level Haemolysis may occur after organ transplantation.
stabilized and the reticulocytosis gradually subsided. Well-known causes of haemolysis are medication, infec-
The medication was left unchanged and transfusions tion, and microangiopathy. It is important to include were not necessary. From day 66 the haemoglobin graft-versus-host antibody formation in the differential started to rise and the LDH fell to normal values. The diagnosis. We present two cases illustrating the role of direct antiglobulin test was negative on day 145. The the graft in antibody formation, and briefly discuss patient has remained in good health until now, 2 years some aspects important to the clinician involved in after the transplantation. renal transplantation.
Case 2

Case reports
A 62-year-old man with end-stage renal failure of unknown cause received a 3-antigen matched cadaveric Case 1 kidney transplant. The patient's blood group was A, rhesus positive (ccDEE) and the donors blood group A 53-year-old man with end-stage renal disease due to was A, rhesus negative (ccdee). The postoperative adult polycystic kidney disease received a 2-antigen course was uneventful and the patient was discharged matched cadaveric kidney transplant. The blood group on the eighth day. His medication consisted of of the patient was B, rhesus positive, and the blood cyclosporin 100 mg b.i.d., prednisone 10 mg b.i.d., group of the donor was O, rhesus positive. The postmycophenolate mofetil 2000 mg b.i.d., famotidine operative course was complicated by a haemorrhage 20 mg, isoniazide 300 mg, pyridoxine 20 mg and and a temporary decline in renal function due to co-trimoxazole 480 mg. On day 18 we received a messcyclosporin toxicity. No transfusions were given. The age from Eurotransplant that haemolysis had occurred patient was discharged on day 18 with a good graft in the recipients transplanted with the liver and the function (creatinine 155 mmol/l ). His medication conlungs of the same donor. In both patients anti-D sisted of cyclosporin 325 mg b.i.d., prednisone 10 mg antibodies had been found. Although there were no b.i.d., mycophenolate mofetil 500 mg b.i.d., omepraclinical signs of haemolysis we tested our patient for zole 20 mg, and co-trimoxazole 480 mg. On day 27 the antibodies. On day 20 the direct antiglobulin test was haemoglobin dropped from 5.7 to 4.5 mmol/l. A slight positive with polyspecific and anti-IgG antisera (titre rise in unconjugated bilirubin (24 mmol/l ), LDH (450 128). The serum and an eluate of the patient's erythro-U/l ), and a reticulocytosis (108%) were observed; a cytes contained anti-D antibodies. The direct antidiagnosis of haemolytic anaemia was made.
globulin test remained positive until day 84; the indirect There was no evidence of microangiopathy, infecantiglobulin test was negative from day 51. In contrast tion, or a metabolic disturbance. Drug-induced haemoto the other recipients no signs of haemolysis developed lysis was considered, but in view of the blood group in our patient. Retrospectively anti-D antibodies were mismatch we first looked for the presence of erythroalso found in the donor's serum. cyte antibodies. Indeed, the direct antiglobulin test was positive with polyspecific and anti-IgG antiglobulin sera (anti-IgG titre 32). The serum and an eluate of Discussion the patient's erythrocytes contained anti-B antibodies. A screening panel for irregular antibodies remained Haemolysis after kidney transplantation is a challennegative. These results confirmed the diagnosis of a ging problem and several possible causes must be considered (see Table 1 ). In most cases the haemolysis angiopathic haemolytic anaemia [1] . Co-trimoxazole Table 1 . Causes of haemolytic anaemia after kidney transplanta-on the B-cell-mediated secondary immune response, tion [2, 4] antibody production could be more frequent in cyclosporin-treated patients [5, 14, 17] [5] . No data are available regarding possible effects of Metabolic hypophosphataemia mycophenolate mofetil. The incidence of antibody formation appears to depend on the transplanted organ mass: it was found more often after heart/lung and liver transplantation than after kidney transplantation. and dapsone, used as prophylactic agents against Pneumocystis carinii infections, cause haemolysis No influence was found for sex, pregnancies, race, ABH secretor status, or cadaveric vs living donor via oxidative denaturation of haemoglobin [2] . Preparations of antithymocyte globulin, used as an organs. In most cases haemolysis was mild, but severe cases requiring massive blood transfusions or leading antirejection treatment, sometimes contain antierythrocyte antibodies [3] . Other known causes of to acute renal failure have been described [5] .
Although prospective studies regarding the incidence haemolysis are severe hypophosphataemia, which is often present in the first weeks after kidney transplanta-of rhesus antibody formation are lacking, this seems to be a rare event. Only nine cases had been described, tion, and infections such as Mycoplasma pneumoniae [2] .
of which seven had haemolysis. Antibodies were directed against several rhesus antigens, mainly c and D. An intriguing source of haemolysis after transplantation is the graft. Two separate mechanisms can be In most of these cases the donor had been sensitized before transplantation [5, 18, 19] . This finding, distinguished: erythrocytes can be damaged mechanically by microangiopathy in the graft, resulting from together with the discrepancy between the proportion of transplantation of Rh(D)-negative organs into rejection, the haemolytic-uraemic syndrome or the use of cyclosporin [1] . Alternatively, haemolysis may be Rh(D)-positive recipients (about 15%) and the apparently much lower incidence of formation of Rhesusthe result of a graft-versus-host disease. In these cases, donor lymphocytes transplanted with the graft produce antibodies, strongly supports the assumption that antierythrocyte antibodies are produced only via a secondantibodies against 'minor mismatched' erythrocyte antigens of the recipient [4] [5] [6] [7] [8] [9] [10] . 'Minor mismatched' ary immune response.
Data on a possible relationship between antibody or 'non-identical' transplantation refers to transplantation of a blood group O organ into a non-O recipient, formation and kidney graft survival have been contradictory [20, 21] . Ramsey found that if haemolysis transplantation of a non-AB organ into an AB recipient, or a rhesus non-identical transplantation [4, 5] . By occurred, graft survival was decreased after liver transplantation but not after kidney transplantation [5] . allotyping of the antibodies it has been demonstrated unequivocally that the antibodies are of donor origin The largest and most recent report comes from the UNOS registry. The incidence of early graft rejection [11] [12] [13] [14] [15] . Also, irradiation of the graft largely prevented the formation of these antibodies [14] . In one recently in six HLA-antigen matched, ABO-non-identical grafts was higher than in the ABO-identical grafts, but one described case of a heart-lung transplantation, leukocytes of donor origin have been identified in the and three year graft survival were identical [22] .
Several measures have been proposed to prevent recipient's lungs and peripheral blood using a PCR for human leukocyte antigen class II genotype [16 ] .
antibody-induced haemolysis or its complications after solid-organ transplantation: avoidance of transplantaThe formation of antibodies against erythrocytes by graft-derived lymphocytes has been described in over tion of lymphocytes as much as possible by flushing the graft thoroughly and by removing lymph nodes 100 case reports. Ramsey analysed 106 cases published by 1991, mostly involving recipients of a kidney (n= from the perirenal fat [23], use of the monoclonal antibody OKT3 instead of the polyclonal antithymo-46) or liver (n=45) transplant [5] . All cases dealt with the formation of ABO or rhesus antibodies. Although cyte globulin [23] , and performing serial direct antiglobulin testing and addition of cyclophosphamide to conceivable, the formation of antibodies against other erythrocyte antigens, leading to haemolysis after the immunosuppressive therapy if antibody production is detected [11] . kidney transplantation, has never been described.
ABO-antibodies, mainly of the IgG class, appeared The value of these prophylactic measures is not proven. In our opinion routine application of these within a few days after transplantation. Haemolysis developed in about half of these patients at a median measures is not required since haemolysis most often is mild and resolves spontaneously [5] . If haemolysis of 10 days after transplantation. The antibodies generally disappeared within 2 months but sometimes were is severe (decline in graft function, severe hyperbilirubinaemia) several approaches are possible: a course of present much longer. These findings are consistent with a secondary immune response by previously primed plasmapheresis could be given [11, 23] , cyclosporin could be replaced by another immunosuppressive agent B-lymphocytes [5, 17] . As cyclosporin is a more selective inhibitor of T-cell function and has only little effect [ should be of donor type to avoid further haemolysis 10. Watzke H, Kovarik J, Gassner H. A permissive effect of [5] . 
